| Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia B Li, SW Brady, X Ma, S Shen, Y Zhang, Y Li, K Szlachta, L Dong, Y Liu, ... Blood, The Journal of the American Society of Hematology 135 (1), 41-55, 2020 | 224 | 2020 |
| Effect of dasatinib vs imatinib in the treatment of pediatric Philadelphia chromosome–positive acute lymphoblastic leukemia: A randomized clinical trial S Shen, X Chen, J Cai, J Yu, J Gao, S Hu, X Zhai, C Liang, X Ju, H Jiang, ... JAMA oncology 6 (3), 358-366, 2020 | 190 | 2020 |
| Germline genetic IKZF1 variation and predisposition to childhood acute lymphoblastic leukemia ML Churchman, M Qian, G Te Kronnie, R Zhang, W Yang, H Zhang, ... Cancer cell 33 (5), 937-948. e8, 2018 | 178 | 2018 |
| TP53 germline variations influence the predisposition and prognosis of B-cell acute lymphoblastic leukemia in children M Qian, X Cao, M Devidas, W Yang, C Cheng, Y Dai, A Carroll, ... Journal of clinical oncology 36 (6), 591, 2018 | 154 | 2018 |
| Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBP M Qian, H Zhang, SKY Kham, S Liu, C Jiang, X Zhao, Y Lu, C Goodings, ... Genome research 27 (2), 185-195, 2017 | 125 | 2017 |
| A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adults V Perez-Andreu, KG Roberts, H Xu, C Smith, H Zhang, W Yang, ... Blood, The Journal of the American Society of Hematology 125 (4), 680-686, 2015 | 124 | 2015 |
| Inherited coding variants at the CDKN2A locus influence susceptibility to acute lymphoblastic leukaemia in children. Nature Communications 6, 2015 | 85 | 2015 |
| PDGFRB mutation and tyrosine kinase inhibitor resistance in Ph-like acute lymphoblastic leukemia Y Zhang, Y Gao, H Zhang, J Zhang, F He, A Hnízda, M Qian, X Liu, ... Blood, The Journal of the American Society of Hematology 131 (20), 2256-2261, 2018 | 71 | 2018 |
| Anti-CLL1 chimeric antigen receptor T-cell therapy in children with relapsed/refractory acute myeloid leukemia H Zhang, P Wang, Z Li, Y He, W Gan, H Jiang Clinical Cancer Research 27 (13), 3549-3555, 2021 | 68 | 2021 |
| Pulse therapy with vincristine and dexamethasone for childhood acute lymphoblastic leukaemia (CCCG-ALL-2015): an open-label, multicentre, randomised, phase 3, non-inferiority trial W Yang, J Cai, S Shen, J Gao, J Yu, S Hu, H Jiang, Y Fang, C Liang, X Ju, ... The Lancet Oncology 22 (9), 1322-1332, 2021 | 65 | 2021 |
| Preferential eradication of acute myelogenous leukemia stem cells by fenretinide H Zhang, JQ Mi, H Fang, Z Wang, C Wang, L Wu, B Zhang, M Minden, ... Proceedings of the National Academy of Sciences 110 (14), 5606-5611, 2013 | 62 | 2013 |
| Prognostic factors for CNS control in children with acute lymphoblastic leukemia treated without cranial irradiation J Tang, J Yu, J Cai, L Zhang, S Hu, J Gao, H Jiang, Y Fang, C Liang, X Ju, ... Blood, The Journal of the American Society of Hematology 138 (4), 331-343, 2021 | 58 | 2021 |
| Novel susceptibility variants at the ERG locus for childhood acute lymphoblastic leukemia in Hispanics M Qian, H Xu, V Perez-Andreu, KG Roberts, H Zhang, W Yang, S Zhang, ... Blood, The Journal of the American Society of Hematology 133 (7), 724-729, 2019 | 46 | 2019 |
| Whole-genome noncoding sequence analysis in T-cell acute lymphoblastic leukemia identifies oncogene enhancer mutations. YJJ Hu S, Qian M, Zhang H, Guo Y, Yang J, Zhao X, He H, Lu J, Pan J, Chang M ... Blood 129 (24), 3264-3268, 2017 | 40* | 2017 |
| Successful anti-CLL1 CAR T-cell therapy in secondary acute myeloid leukemia H Zhang, WT Gan, WG Hao, PF Wang, ZY Li, LJ Chang Frontiers in oncology 10, 685, 2020 | 38 | 2020 |
| Coordinated regulation of the immunoproteasome subunits by PML/RARα and PU. 1 in acute promyelocytic leukemia XW Yang, P Wang, JQ Liu, H Zhang, WD Xi, XH Jia, KK Wang Oncogene 33 (21), 2700-2708, 2014 | 35 | 2014 |
| Noncoding genetic variation in GATA3 increases acute lymphoblastic leukemia risk through local and global changes in chromatin conformation H Yang, H Zhang, Y Luan, T Liu, W Yang, KG Roberts, M Qian, B Zhang, ... Nature genetics 54 (2), 170-179, 2022 | 34 | 2022 |
| Clinical ascertainment of health outcomes in Asian survivors of childhood cancer: a systematic review LHJ Poon, CP Yu, L Peng, CLY Ewig, H Zhang, CK Li, YT Cheung Journal of Cancer Survivorship 13, 374-396, 2019 | 33 | 2019 |
| Reactive oxygen species in eradicating acute myeloid leukemic stem cells H Zhang, H Fang, K Wang Stem cell investigation 1, 2014 | 32 | 2014 |
| ARID5B Influences Antimetabolite Drug Sensitivity and Prognosis of Acute Lymphoblastic Leukemia H Xu, X Zhao, D Bhojwani, S E, C Goodings, H Zhang, NL Seibel, W Yang, ... Clinical Cancer Research 26 (1), 256-264, 2020 | 28 | 2020 |
